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In the past, the genetically diabetic-obese diabetes/diabetes (db/db)a n dobese/obese (ob/ob) mouse strains were used to investigate
mechanisms of diabetes-impaired wound healing. Here we determined patterns of skin repair in genetically normal C57Bl/6J
mice that were fed using a high fat diet (HFD) to induce a diabetes-obesity syndrome. Wound closure was markedly delayed in
HFD-fed mice compared to mice which had received a standard chow diet (CD). Impaired wound tissue of HFD mice showed
a marked prolongation of wound inﬂammation. Expression of vascular endothelial growth factor (VEGF) was delayed and
associated with the disturbed formation of wound margin epithelia and an impaired angiogenesis in the reduced granulation
tissue. Normal wound contraction was retarded and disordered. Wound disorders in obese C57Bl/6J mice were paralleled by a
prominent degradation of the inhibitor of NFκB( I κB-α) in the absence of an Akt activation. By contrast to impaired wound
conditions in ob/ob mice, late wounds of HFD mice did not develop a chronic inﬂammatory state and were epithelialized after 11
days of repair. Thus, only genetically obese and diabetic ob/ob mice ﬁnally developed chronic wounds and therefore represent a
better suited experimental model to investigate diabetes-induced wound healing disorders.
1.Introduction
Diabetesmellitushasseenanextensiveglobalincrease,which
had been predicted nearly a decade ago [1]. Diabetic skin
ulcerations represent a severe complication of the disease,
and more important, a still unmet medical problem associ-
atedwithsigniﬁcantmortality[2,3].Thelifetimeriskforany
diabetic patient to develop this complication is about 15%
[4]. Moreover, diabetic ulcers have a poor prognosis and the
3-year survival rate after amputations are only between 50
and 59% [5, 6]. Predisposing factors (neuropathy, ischemia),
which lead to foot ulceration [7], are all but impossible
to imitate using the respective animal models of wound
healing. Nevertheless, diabetic and obese rodents have long
been used as animal models to unravel molecular and
cellular mechanisms that might form the basis of or at least
contribute to diabetes-disturbed wound conditions.
In particular, the genetically obese (ob/ob) and diabetes
(db/db) mouse strains [8]hadbeen favoredasanimal models
of diabetes-impaired skin repair [9–13]. Upon wounding,
ob/ob and db/db mice develop severely disordered wound
conditions. Seminal studies using these animals identiﬁed
substantial mechanisms that contributed to the observed
failure of tissue regeneration. The most severe defects in
terms of impaired reepithelialization and granulation tissue
formation were strongly associated with a loss of function of
diverse growth factors that drive keratinocyte, ﬁbroblast and
endothelial cell functions [10–12, 14–16] in the presence of
a greatly augmented wound inﬂammatory response [13, 17,
18].
It is noteworthy to allude to the fact that these earlier
studies in ob/ob and db/db mice were focused mainly on the
diabetic phenotype of the animals. However, it also turned
out that the diabetic phenotype of these animals appears2 Experimental Diabetes Research
to be functionally connected to their huge adipose tissue
mass [19]. At present, a novel concept has evolved that con-
vincingly implicates an adipose tissue-driven activation of
macrophages as the central cause of insulin-resistance under
conditions of severe obesity [20–22]. This basic concept
appeared to also prove true for diabetes-impaired healing in
obese mice, as speciﬁc depletion of macrophages from sites
of injury markedly improved tissue repair upon wounding
and transplantation [18, 23].
By contrast to the intensive use of genetically diabetic
and obese mice in terms of wound repair, there are no data
available to date that are based on a diet-induced diabetic
and obese phenotype in wild-type mice. Here, we wounded
genetically normal C57Bl/6J mice which had been rendered
obese and diabetic using a high-fat diet (HFD) for 27 weeks.
Consistent with ﬁndings in ob/ob mice, HFD-fed animals
exhibited a delayed wound closure that was associated
with impaired wound reepithelialization and contraction,
a prolonged wound inﬂammation and a markedly disturbed
activation of central intracellular signaling pathways. Our
data suggest that the genetically diabetic ob/ob mouse
represents a suitable animal model to describe mechanisms
of impaired wound healing under conditions of an obesity-
associated insulin-resistance.
2.Materialsand Methods
2.1. Animals. Female C57Bl/6J (wild-type) and C57Bl/6J-
ob/ob mice were obtained from The Jackson Laboratories
(Bar Harbor, ME) and maintained under a 12h light/12h
dark cycle at 22◦C.
2.2. Feeding of Mice. At the age of 6 weeks (for C57Bl/6J) or
12 weeks (for C57Bl/6J-ob/ob), mice were caged individually
and monitored for body weight. For the high-calorie diet
study, six-week-old C57Bl/6J wild-type mice (n = 30)
were maintained ad libitum on water and a high-fat diet
(HFD) (D12331, Research Diets Inc., New Brunswick, NJ)
for 190 days to induce an obese and diabetic phenotype in
the animals. The HFD contained high-fat (35.8%), protein
(23.0%)and carbohydrate (35.5%).The caloriesprovidedby
fat, proteinand carbohydrate were 58.0%, 16.4% and 25.5%,
respectively. C57Bl/6J control mice received water and
acontrolchowdiet(CD)adlibitumfor190dayswithcalories
provided by fat (11%), protein (23%) and carbohydrate
(65%). C57Bl/6J-ob/obmice were fed with a CD throughout
the experiment.
2.3. Oral Glucose Tolerance Test (OGT). CD- and HFD-fed
mice or ob/ob mice were starved for 16h. Mice were subse-
quentlyappliedorallywithglucose(1.5gperkgbodyweight)
bygastrogavage. Bloodglucoselevelswere determinedbefore
and 60min following glucose application.
2.4. Wounding of Mice. Following the feeding period of 190
days,CD-andHFD-fedmicewere33weeksoldatwounding.
C57BL/6J-ob/ob mice were wounded at the age of 12 weeks.
Wounding of mice was performed as described previously
[24, 25]. Brieﬂy, mice were anaesthetized with a single i.p.
injection of ketamine (80mg/kg body weight)/xylazine
(10mg/kg body weight). The hair on the back of each mouse
was cut, and the back was subsequently wiped with 70%
ethanol. Six full-thickness wounds (5mm in diameter, 3-
4mm apart) were made on the back of each mouse by
excisingtheskinandtheunderlyingpanniculus carnosus.The
wounds were allowed to form a scab. Skin biopsy specimens
were obtained from the animals 1, 3, 5, 7, and 11 days after
injury. At each time point, an area which included the scab,
the complete epithelial and dermal compartments of the
wound margins, the granulation tissue, and parts of the
adjacent muscle and subcutaneous fat tissue was excised
from each individual wound. As a control, a similar amount
of skin was taken from the backs of nonwounded mice.
For each experimental time point, tissue from four wounds
each from four animals (n = 16 wounds, RNA analysis)
and from two wounds each from four animals (n = 8
wounds, protein analysis) were combined and used for RNA
and protein preparation. Nonwounded back skin from four
animals served as a control. All animal experiments were
carried out according to the guidelines and were approved
by the local Animal Ethics Review Board.
2.5. Analysis of Serum from CD- or HFD-Fed and ob/ob Mice.
Blood glucose levels were determined using the AccuTrend
sensor (Roche Biochemicals, Mannheim, Germany). Serum
insulin, leptin and tumor necrosis factor (TNF-α)w e r ea n a -
lyzed by Luminex (Biotrend, D¨ usseldorf, Germany) as de-
scribed by the manufacturer.
2.6. RNA Isolation and RNase Protection Analysis. RNA
isolation and RNase protection assays were carried out as
described previously [25, 26]. If not indicated otherwise,
every experimental time point depicts 12 wounds (n =
12) isolated from four individual mice (n = 4) for all
RNase protection assays analyzing wound tissue samples. All
samples were quantiﬁed using PhosphoImager PSL counts
per 15μg of total wound RNA. Glyceraldehyde phosphate
dehydrogenase (GAPDH) hybridization was used as a load-
ing control. The cDNA probes were cloned using RT-PCR.
The probes corresponded to nt 425 (exon 1) to 170 (exon 2)
(for lysozyme M, GenBank accession number M21047), nt
816 to 1481 (for lipocalin, X81627), nt 912 to 1183 (for α-
smooth muscle actin (α-SMA), BC064800.1) or nt 163–317
(for GAPDH, NM002046) of the published sequences.
2.7. Immunohistochemistry. Mice were wounded as de-
scribed above. Animals were sacriﬁced at day 5 and 7 after
injury. Biopsies from skin wounds were isolated from the
back, ﬁxed in formalin or in zinc ﬁxative solution (0.05%
CaAc·2H2O, 0.5 ZnAc·2H2O,0.5%ZnCl2 in0.1MTris-HCl,
pH 7.4) and subsequently embedded in paraﬃn. Sections
(4μm) were subsequently incubated over night at 4◦C
with antisera raised against murine F4/80 (AbD Serotec,
D¨ usseldorf, Germany), Ly-6G (Gr-1) (BD Pharmingen,
Heidelberg, Germany), VEGF (Santa Cruz, Heidelberg, Ger-
many), CD31 (Chemicon, Eschborn, Germany), or α-SMAExperimental Diabetes Research 3
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Figure 1:Body weightanddiet-induced metabolicchangesin mice.(a)Weightgain inCD-fed, HFD-fed orob/obmiceasindicated. (b) CD-
fed, HFD-fed and ob/ob mice were starved for 16h. Basal blood glucose levels (left panel) and blood glucose levels (60min) during an OGT
(rightpanel) were determined. (c) CD-fed, HFD-fed andob/obmicewere starved for16h.Serum insulin(leftpanel) andleptin (rightpanel)
were determined. ∗∗P<. 01; ∗P<. 05 versus CD-fed mice. Bars indicate the mean ± SD obtained from 26 individual animals.
(Sigma, Taufkirchen, Germany). Primary antibodies were
detected using a biotinylated secondary antibody. The slides
were subsequently stained with the avidin-biotin-peroxidase
complex system (Santa Cruz) using 3,3-diaminobenzidine-
tetra-hydrochloride or Fast Red Substrate-Chromogen Sys-
tem (Dako, Hamburg, Germany) as chromogenic substrates.
Finally, sections were counterstained with hematoxylin and
mounted.
2.8. Preparation of Protein Lysates and Western Blot Analysis.
Skin and wound tissue biopies were homogenized in lysis
buﬀer(1% Triton X-100, 137mM NaCl, 10% glycerol,1mM
dithiothreitol, 10mM NaF, 2mM Na3VaO4,5m Me t h y l e n e -
diaminetetraacetic acid, 1mM phenylmethylsulfonylﬂuo-
ride, 5ng/ml aprotinin, 5ng/ml leupeptin, 20mM Tris/HCl,
pH 8.0) and cleared by centrifugation. Protein concentra-
tions were determined using the BCA Protein Assay Kit
(Pierce Inc., Rockford, IL, USA). Fifty micrograms of total
p r o t e i nf r o ms k i nl y s a t e sw e r es e p a r a t e du s i n gS D Sg e le l e c -
trophoresis. After transfer to a nitrocellulose membrane,
speciﬁc proteins were detected using antisera raised against
F4/80 (AbD Serotec), Ly-6G (Gr-1) (BD Pharmingen), cy-
clooxygenase (Cox)-2 (Cayman, Ann Arbor, MI, USA), α-
SMA (Dako, Glostrup, Denmark), phospho-signal trans-
ducer and activator of transcription (STAT)-3 (Y705),
phospho-Akt (S473) (Cell Signalling, Frankfurt, Germany),
inhibitor of nuclear factor κB( I κB)-α (Santa Cruz, Heidel-
berg, Germany) and β-actin (Sigma). A secondary antibody
coupled to horseradish peroxidase and the enhanced chemi-
luminescence (ECL) detection system was used to visualize4 Experimental Diabetes Research
the proteins. Phenylmethylsulfonyl ﬂuoride, dithiothreitol,
aprotinin, NaF and Na3VaO4 were from Sigma. Leupeptin
and ocadaic acid were from BioTrend (K¨ oln, Germany).
The ECL detection system was obtained from Amersham
(Freiburg, Germany).
2.9. Enzyme-Linked Immunosorbent Assay (ELISA). Quan-
tiﬁcation of murine IL-1β, macrophage inﬂammatory
protein (MIP)-2, or vascular endothelial growth factor
(VEGF)165 protein was performed using the respective
murine Quantikine ELISA kits (R&D Systems, Wiesbaden,
Germany) according to the instructions of the manufacturer.
2.10. Analysis of Neoepithelia. Areas of neoepithelia were
determinedusingtheImageJanalysisprogramme(http://rsb.
info.nih.gov/ij/).
2.11. Statistical Analysis. Data are shown as means ± SD.
Data analysis was carried out using the unpaired Student’s
t test with raw data. Statistical comparison between more
than two groups was carried out by analysis of variance
(ANOVA, Dunnett’s method).
3.Results
3.1. High-Fat Diet (HFD) Induces Obesity and Insulin Resis-
tance and Delays Normal Wound Closure. C57BL/6J wild-
type mice were fed using a HFD, which provides 58%
of calories as saturated fatty acids for a period of 190
days. Mice were 6 weeks old, when feeding was started.
Animals of the control group received a standard control
chow diet (CD). The long-term uptake of the HFD caused
a signiﬁcant increase in body weight (Figure 1(a)). The
HFD-induced obesity was paralleled by the development
of a distinct insulin-resistance in the mice. Starved mice
of the HFD group exhibited elevated levels of basal blood
glucose (Figure 1(b), left panel) and a severely impaired
clearance of acutely increased blood glucose levels during
an OGT (Figure 1(b), right panel). The observed impaired
glucose tolerance in HFD-treated mice was accompanied
by a hyperinsulinaemic state and markedly raised levels of
circulating leptin (Figure 1(c)), which both represent well-
described features of a developing HFD-induced type 2
Diabetes mellitus in mice [27]. Inline with published data,
ob/ob mice were severely insulin resistant (Figure 1(b))a n d
hyperinsulinaemic [28]( Figure 1(c), left panel). Due to the
functional loss of the obgene product leptin [29], ob/obmice
were deﬁcient of circulating leptin (Figure 1(c),r i g h tp a n e l ) .
We started wounding of mice, when we had assured
the presence of a combined overweight/obese and diabetic
phenotype in the HFD-feeding group (Figure 1). Wounding
was carried out in HFD-induced obese and diabetic mice,
CD-fed lean mice and in genetically obese and diabetic
ob/obmice. After wounding, we generally observed a marked
delay in acute wound closure in mice with an obese and
diabetic phenotype (HFD, ob/ob). Five days upon injury,
impaired wounds in HFD-fed and ob/obmice were increased
in diameter (Figure 2(a), left panel). This ﬁnding was
supported by histologic analyses of wound cross-sectional
areas, which demonstrated an enlarged distance of wound
margin neoepithelia (Figure 2(a), right panel). In support of
these data, wound margin epithelia of HFD and ob/ob mice
were also reducedin size (Figure 2(b)).Atday7afterwound-
ing, wounds of CD mice were completely reepithelialized,
whereas epithelialization was still incomplete in HFD mice
(Figure 2(a), right panel and Figures 3(c) and 4(c) HFD).
In addition, wounds of ob/ob mice were impaired at day 5
and 7 after wounding (Figure 2(a), middle and right panel)
and even after 11 days of healing (data not shown). At this
time point, wounds of CD and HFD mice were completely
closed (data not shown).
3.2. Skin Injury Changes Levels of Circulating Mediators.
Remarkably, wounding of skin tissue also mediated marked
systemic eﬀects. The levels of circulating insulin showed
a distinct reduction upon wounding in CD- and HFD-
treated mice, but not ob/ob mice (Figure 2(c)). Further-
more, circulating leptin was reduced in CD and HFD
mice (Figure 2(d)). However, both insulin and leptin levels
remained signiﬁcantly higher in high-caloric treated mice
during repair. Ob/ob mice did not produce the functional
ob gene product [28, 29]. Basal TNFα levels were low in
all animals, not dependent on obesity and not altered upon
wounding (Figure 2(e)).
3.3. Prolonged Presence of Wound Macrophages and Neu-
trophils in HFD and ob/ob Mice. A controlled wound
inﬂammation is pivotal to normal skin repair [30–32]
and has been described to be augmented in db/db and
ob/ob mice [13, 17]. Therefore, we determined the inﬂux
of macrophages (Figure 3) and neutrophils (Figure 4)i n t o
the healing tissue, as we hypothesized that increased num-
bers of leukocytes could be associated with the observed
impaired healing conditions in HFD mice. To do so, we
used the expression of distinct cellular markers restricted
for macrophages (lysozyme M) or neutrophils (lipocalin),
which represent constitutively expressed genes in these cell
types and allow an overall quantiﬁcation of cell numbers
of the respective inﬁltrate at the wound site [13, 17].
In general, ob/ob mice exhibited the most severe dysreg-
ulation of macrophage and neutrophil inﬂux: lysozyme
M( Figure 3(a)) and lipocalin (Figure 4(a))m R N Al e v e l s
remained largely elevated upon injury. This was consistent
with strong and long-lasting macrophage-speciﬁc F4/80 [33]
(Figure 3(b), lower panel) or Ly6G (GR-1)-speciﬁc signals
[34]( Figure 4(b), lower panel) in immunoblots from late
wound tissue lysates. By contrast, the kinetics for lysozyme
M and lipocalin mRNA expression were only moderately
altered between CD and HFD mice (Figures 3(a) and 4(a)),
but both the macrophage- or neutrophil-speciﬁc expression
of the respective F4/80 (Figure 3(b))a n dL y 6 G( Figure 4(b))
proteins was markedly increased at the end of acute
repair in HFD mice. This observation was also consistent
with increased numbers of both cell types as assessed by
immunohistochemical analysis of wound tissue (Figures 3(c)
and 4(c)).Experimental Diabetes Research 5
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Figure 2 :W o u n dc l o s u r ea n ds y s t e m i ce ﬀects of wounding. (a) 5-day wounds in CD-fed, HFD-fed and ob/ob mice (left panel). Distances of
neoepithelia in cross-sectional areas of 5-day and 7-day wounds of CD-fed, HFD-fed and ob/ob mice (right panels). (b) Histologies showing
wound neoepithelia of CD, HFD or ob/ob mice as indicated. Scale bars = 500μm. The epithelial margins are indicated by a yellow line. Panel:
areas ofwoundmarginneoepithelia in CD, HFD and ob/obmice. ∗∗P<. 01versus CD-fed mice.Bars indicate the mean ± SD obtainedfrom
8w o u n d s( n = 8) from 4 individual animals (n = 4 ) .( c )S e r u mi n s u l i n ,( d )L e p t i na n d( e )T N F - α levels in CD-fed, HFD-fed or ob/ob mice
before wounding and during diﬀerent days of healing as indicated. ∗∗P<. 01; ∗P<. 05 versus CD-fed mice. Each single experimental time
point depicts the mean ± SD obtained from 4 individual animals (n = 4).
3.4. Expression of Proinﬂammatory Marker Proteins at the
Wound Site. Next, we determined the expression pattern of
the prototypic chemokine MIP-2 upon skin wounding, as
chemokinerelease precedestheinﬁltration ofleukocytesinto
thewound site [13, 17, 32,35]. Again, ob/obmice showed the
most pronounced dysregulation of MIP-2 protein expression
with highest levels in late wound tissue (day 5 and 7)
(Figure 5(a)). Interestingly, the presence of MIP-2 protein
started to diﬀer not before the end of acute repair at
day 5 after wounding between all experimental groups. In
particular, the delayed healing in HFD mice was paralleled
by still increased MIP-2 levels at day 7 of repair, when MIP-2
w a sn e a r l yg o n ei nC Dm i c e( Figure 5(a)).
IL-1β is released from activated myeloid cells during
acute inﬂammatory processes and represents an indicator
molecule for inﬂammatory conditions [36–38]. IL-1β was
induced upon wounding in CD, HFD and ob/ob mice,
however, HFD mice revealed a delayed rise of this cytokineExperimental Diabetes Research 7
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Figure 3: Macrophages in wound tissue. (a) Expression of lysozyme M mRNA in nonwounded back skin and wound tissue isolated from
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(Figure 5(b)). The acute wound response then exhibited
comparable levels of IL-1β in CD and HFD mice. Again, IL-
1β levels remained elevated particularly in 7-day late acute
wounds of HFD and ob/ob mice. IL-1β then persisted in late
chronic wounds of ob/ob mice, but declined to baseline in
healing wounds of CD and HFD mice (day11)(Figure 5(b)).
Cox-2 is known to be diﬀerentially expressed in skin
wounds [39]. Here, we observed the rapid induction of
Cox-2 protein in all mice upon wounding (Figure 5(c)).
In CD mice, Cox-2 expression started to decline after day
5 after wounding (Figure 5(c), upper panel). By contrast,
Cox-2 protein remained increased also at day 7 of repair in
HFD mice (Figure 5(c), middle panel), whereas ob/ob mice
exhibited the most pronounced dysregulation even in late
wound tissue (Figure 5(c),l o w e rp a n e l ) .
3.5. Wound Angiogenesis is Disturbed in HFD-Induced Obese
and Diabetic Mice. Angiogenic processes at the wound
essentially contribute to normal skin repair [30, 31]. VEGF is
pivotal to wound angiogenesis [40]. Thus, VEGF expression
and wound angiogenesis have been shown to be severely
impaired in db/db and ob/ob mice [16, 41, 42]. Here, we
show thatwoundVEGF levelswereonlymoderatelydiﬀerent
between CD and HFD mice at day 5 of repair (Figure 6(a)).8 Experimental Diabetes Research
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Inline with published data [25, 43], it is important here
that VEGF was expressed in wound margin keratinocytes
(Figure 6(b)). The formation of well-developed, VEGF-
expressing wound margin epithelia was delayed in HFD
mice (Figure 6(b); refer also to Figure 2(b)). When wounds
of CD mice were epithelialized at day 7 after wounding
(Figure 6(b); refer to Figure 2(a)), wound margin epithelia
ofHFDmice still expressed VEGF protein (Figure 6(b),ri gh t
panels). Using the endothelialmarker CD31 to detectwound
angiogenesis, we showed that wound VEGF signals appeared
to be translated into a robust angiogenic response only in
CD mice (Figure 6(c), left panel). By contrast, HFD mice
exhibited a severely disturbed angiogenic response even at
day 7 of repair (Figure 6(c),r i g h tp a n e l ) .
3.6. Impaired Myoﬁbroblast Diﬀerentiation and Wound Con-
traction in HFD-Induced Obese and Diabetic Mice. Next, we
investigated the appearance of myoﬁbroblasts at the wound
site, as we had observed a delay in wound contraction in
HFD and ob/ob mice (Figure 2(a)). To this end, we assessedExperimental Diabetes Research 9
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the α-SMA mRNA and protein expression (Figure 7)a s
a marker of the ﬁnal diﬀerentiation of myoﬁbroblasts [44].
The failure of ﬁbroblasts to diﬀerentiate into myoﬁbroblasts
at the wound site in HFD mice could be shown by the
delayed appearance of α-SMA mRNA (Figure 7(a),l e f t
panel) and protein (Figure 7(b)) in the animals. Here the
de novo appearance of α-SMA protein was not visible
earlier than day 7 of repair. Inline, immunohistochemistry
showed myoﬁbroblasts that were primarily located at the
wound margins in HFD mice in the presence of a disturbed
wound contraction (Figure 7(c),r i g h tp a n e l ) .B yc o n t r a s t ,
epithelialized wounds of CD mice were characterized by
a well-deﬁned and myoﬁbroblast-mediated contraction of
wound tissue (Figure 7(c), left panel). We could not detect
any α-SMA mRNA and protein expression in wounds of
ob/ob mice throughout the complete period of healing
(Figures 7(a) and 7(b)).
3.7. Modiﬁed Activation of Inﬂammatory Signaling Pathways
in Obese and Diabetic Mice. Finally, we investigated central
prototypical signaling pathways in normal and impaired
wound tissue. The activation of STAT-3 [45], Akt [42]a n d
nuclear factor κB( N F κB) [46, 47]i si m p l i c a t e di ns k i n
wounds. Here we observed a STAT3 activation kinetic that
appeared independent from the obese and diabetic pheno-
type: STAT3 phosphorylation (Y705) was rapidly induced10 Experimental Diabetes Research
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upon injury and the activation started to decline from day
3 after wounding (Figure 8(a)). By contrast, a prominent
activation of Akt (S473 phosphorylation) was limited to the
acuteinﬂammatory phase ofrepairin lean CDmice, whereas
an Akt activation was absent in wound tissue from obese
and diabetic HFD and ob/ob mice throughout the complete
period of healing (Figure 8(b)). Prior to activation of the
classicalproinﬂammatory NFκBsignalling pathway,theIκBα
protein has to be introduced to proteasomal degradation to
release NFκB proteins for active signalling [47]. Here the
disappearance of IκBα protein paralleled the acute wound
inﬂammatory phase in lean CD mice. The IκBα protein
became visible again in 5-day wound tissue in the animals,
that time point when the resolution of wound inﬂamma-
tion normally occurs (Figure 8(c), upper panel). However,
aprominent IκBαsignalwas stillmissing inHFDmiceat that
time point of repair (Figure 8(c), middle panel). Moreover,
ob/ob mice showed an absence of IκBα over time and thus
an activation of the NFκB pathway even in late wounds
(Figure 8(c),l o w e rp a n e l ) .
4.Discussion
Diabetic ulcerations remain a still unresolved clinical con-
dition with a high mortality [2, 3], that will become more
signiﬁcant with the expected rise in the prevalence of
type 2 diabetes in the next two decades [48]. The failure
of pharmacologic treatment options, with platelet-derived
growth factor-BB as the only exception [49], further adds
to this disappointing clinical situation. Chronic wounds
represent diverse cutaneous lesions that do not undergo the
coordinated progress of normal tissue repair [50]. Despite
the basic necessity of a controlled wound inﬂammation,
granulation tissue formation and reepithelialization [30, 31],
diabetes-impaired wounds appear to have lost the ideal
synchrony of events that lead to rapid healing [50]. AlthoughExperimental Diabetes Research 11
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important intrinsic (neuropathy, vascular problems) or
extrinsic (wound infection, callus formation, pressure to the
site) factors of human diabetic ulceration [50] can only be
stimulated to some extent in animals, there is no alternative
to the use of wound healing models in type 2 diabetic
rodents. Therefore, much of important knowledge with
respect to underlying mechanisms of the diabetic ulceration
has been achieved by using diabetic mice. Early basic papers
in the ﬁeld of wound healing established the use of the
diabetic ob/ob [9]a n ddb/db [11] mouse as models for
impaired wound healing. However, syndromes in both the
db/db and ob/obmouse were not limited toinsulin-resistance
only. The underlying genetic defect in leptin signaling in the
animals [29, 51] additionally causes hyperphagia, hyperin-
sulinemia, hyperglycemia and a marked obesity [8]. These
phenotypic changes are mediated by the loss of leptin action
in the hypothalamus, where the cytokine normally regulates
neuronal and endocrine circuits [52]. For these reasons, the
respective genetic defects in db/db and ob/ob mice mainly
combine a pronounced obesity with an insulin-resistance,
actually generating a model of metabolic syndrome [53].
This is all the more interesting, as obesity-associated
insulin-resistance is currently regarded as a consequence
of persisting low-grade inﬂammatory conditions that orig-
inate in a pathologically altered communication of adipose
tissue leading to macrophage activation [20–22]. Indeed,
the pathophysiologic interconnection between the marked
adipose tissue andmacrophageactivation exhibitsfunctional
consequences for skin repair in ob/ob mice: depletion of
woundmacrophagesbydiﬀerenttechniques(antibodies,clo-
dronate liposomes) markedly improved tissue regeneration
in ob/ob mice [18, 23, 54]. Hence, these studies strongly sug-
gest that the marked signs of obesity, that were inextricably
connected to the type 2 diabetes in the genetically diabetic
and obese ob/ob mouse [8, 29], pivotally contribute to the
observed wound disturbances in the animals.12 Experimental Diabetes Research
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Therefore, itwasreasonableheretoinvestigate cutaneous
tissue repair in a diet-induced mouse model of obesity and
insulin-resistance. Such a study would allow to determine
potential diﬀerences, advantages or short-cuts in the use
of genetically diabetic and obese mice in wound healing
experiments. Our 6-month HFD treatment of mice resulted
in elevated blood glucose and insulin levels in the animals.
This is in accordance to established ﬁndings showing that
a6 - m o n t had libitum exposure to a high-fat, simple car-
bohydrate diet produced obesity, hyperglycemia and hyper-
insulinemia in C57Bl/6J mice [55]. However, it becomes
obvious that the loss of functional leptin in ob/ob mice [29]
resulted in more severe hyperglycaemic and insulinaemic
states [8, 53]. Increased serum leptin levels in HFD-fedExperimental Diabetes Research 13
m i c er e ﬂ e c tt h eg r o w i n ga d i p o s et i s s u ei no b e s ea n i m a l s
[56]. Thus, the determination of endocrine and physiologic
parameters strongly showed that HFD-feeding had resulted
in the development of an obese and diabetic phenotype in
C57Bl/6Jmice.
Not unexpected, our wounding of HFD mice resulted
in a general delay in wound closure. Three main ﬁndings
with respect to tissue repair in HFD mice have to be
accentuated here. First, the main disturbances aﬀected the
acute wound inﬂammatory response, which appeared to be
prolonged. Second, the formation of normal wound margin
epithelia was disturbed, and third, we observed a marked
impairment inmyoﬁbroblast diﬀerentiationandthuswound
contraction. Here, the loss of myoﬁbroblast diﬀerentiation
in wound tissue appeared to be the most prominent dif-
ference between the genetic and the induced mouse model
of diabetes. The absence of myoﬁbroblasts in wounds of
ob/ob mice might reﬂect a direct functional consequence
of a strongly impaired transforming growth factor (TGF)-
β signalling in disturbed wound tissue in the animals. TGF-
β1 represents the essential signal to induce the formation
of contractile bundles in normal wound ﬁbroblasts [44].
Therefore, it is tempting to argue that an augmented wound
inﬂammation in diabetic mice might drive alterations in
the responsiveness of wound ﬁbroblasts to external sig-
nals, as ﬁbroblasts isolated from chronic wounds revealed
a disturbed signaling from the TGF-βII receptor [57]. Inline
with this argumentation, chronic ulcers in humans were
characterized by the suppression of TGF-β receptors I-III
and the subsequent absence of Smad2 phosphorylation [58].
In addition, TNF-α, which exhibits a markedly prolonged
and elevated presence in disturbed wounds of ob/ob mice
[17], has been shown to potently suppress TGF-β1-induced
myoﬁbroblast phenotypic genes in ﬁbroblasts [59]. Thus,
the strongly exacerbated wound inﬂammation in ob/ob mice
(in the study, [17]) appears to contribute to the observed
extensive loss of myoﬁbroblast diﬀerentiation and wound
contraction as a consequence.
In addition, wounding of mice resulted in a noticeable
decrease in circulating insulin and leptin levels, which
reached basal levelsagain at the end ofrepair. Although pub-
lished datadealingwith systemic eﬀectoftrauma are limited,
our ﬁnding appeared consistent with acutely reduced insulin
levels in rats after surgical trauma [60]. Moreover, injury-
mediated decreasing levels of leptin clearly indicate that
circulating levels of this cytokine were not simply a result of
adipose tissue mass [56], but also susceptible to an acute
systemic response such as trauma (wounding).
TheHFD-inducedimpairments inwoundinﬂammation,
reepithelialization, angiogenesis and contraction have to be
considered in relation to published data from wounded
ob/ob mice. In conclusive analogy to conditions in HFD-
treated mice, wounded ob/ob mice also exhibited reduced
wound margin epithelia [10], increased levels of MIP-2, IL-
1β [17]a n dC o x - 2[ 61] protein, a prolonged presence of
neutrophils and macrophages at the wound site [17, 18],
moderately altered wound VEGF levels [41]o ri m p a i r e d
signaling pathways [54] .D u et ot h eo v e r a l lc o n s i s t e n c eo f
wound conditions in both HFD and ob/obmice, it is actually
allowedheretostatethatthedeleteriouseﬀectsofobesityand
diabetes caused a more pronounced impairment and also
delayed healing in ob/obmice. Our ﬁndings from ob/ob mice
show that wound inﬂammation as well as reepithelialization
were severely impaired eventhroughout late repair. Thus, the
underlying leptin deﬁciency in ob/ob mice further ampliﬁed
those impairments in skin repair that could also be observed
in the diet-induced obese and diabetic mouse. Therefore,
our data support the general use of the ob/ob mouse model
to investigate basic mechanisms of diabetes-disturbed skin
repair. As long as these diﬀerences were considered with
respect to a careful and thorough interpretation of data, the
ob/ob mouse holds the strong advantage to show an ampli-
ﬁcation of particularly those injury-induced inﬂammatory
and also tissue responses that were less strongly developed
in a diet-induced mouse model of obesity and diabetes.
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